2-Chlorotrityl Chloride Resin: Loading & Cleavage Protocol

2-Chlorotrityl Chloride Resin is a highly acid-labile, low-racemization solid support widely used in Fmoc-based solid-phase peptide synthesis (SPPS) for loading Fmoc-amino acids, carboxylic acids, and alcohols, enabling mild acidic cleavage to yield protected or unprotected peptides.

Resin Type

Macroporous polystyrene-based trityl chloride resin

Compatibility

Fmoc/tBu solid-phase peptide synthesis strategy

Key Advantage

Minimal racemization during amino acid loading; supports mild cleavage conditions

Cleavage Conditions

Dilute acetic acid/trifluoroethanol/DCM or dilute TFA/DCM mixtures (e.g., 1–5% TFA)

Typical Loading Capacity

0.5–1.5 mmol/g (verify with supplier certificate of analysis)

Related SKU

C590778 — 2-Chlorotrityl Chloride Resin (Aladdin Scientific)

Principle and Overview

2-Chlorotrityl Chloride (2-CTC) Resin is a polystyrene-based solid support functionalized with a 2-chlorotrityl chloride linker. The ortho-chloro substituent on the trityl group increases the steric bulk and electron-withdrawing character of the linker, making it significantly more acid-labile than standard trityl or Wang resins. This property allows peptide chains to be cleaved under very mild acidic conditions (e.g., 1–2% TFA in DCM or AcOH/TFE/DCM mixtures), while standard side-chain protecting groups remain intact.

The resin is ideally suited to: (1) synthesis of fully protected peptide fragments for fragment condensation strategies; (2) preparation of peptide acids, amides, or alcohols; and (3) synthesis of difficult sequences where minimizing racemization during anchoring is critical. The highly reactive trityl chloride group reacts rapidly with the carboxyl group of the first Fmoc-amino acid in the presence of a hindered base such as DIPEA, forming a stable ester linkage with minimal epimerization.

Materials and Equipment

• 2-Chlorotrityl Chloride Resin (Aladdin Scientific, SKU: C590778)
• Fmoc-protected amino acid of choice (first residue)
• Anhydrous N,N-dimethylformamide (DMF)
• Dichloromethane (DCM), anhydrous
• Diisopropylethylamine (DIPEA), anhydrous
• Methanol (MeOH), anhydrous
• Piperidine (20% v/v in DMF for Fmoc removal)
• Cleavage cocktail: e.g., AcOH/TFE/DCM (1:1:8, v/v/v) or 1–5% TFA in DCM
• Coupling reagents (e.g., HBTU/HOBt, HATU, or DIC/Oxyma)
• Sintered glass funnel or manual peptide synthesis vessel
• Rotary evaporator or nitrogen stream for solvent removal
• Analytical balance, magnetic stirrer, inert atmosphere capability (optional)

Step-by-Step Protocol

Step 1: Resin Swelling

Weigh the required amount of 2-CTC Resin into a peptide synthesis vessel. Add anhydrous DCM (approximately 10 mL per gram of resin) and allow the resin to swell for 30 minutes at room temperature with gentle agitation. Drain the solvent by filtration.

Step 2: Loading the First Fmoc-Amino Acid

Dissolve the Fmoc-amino acid (typically 3–5 equivalents relative to resin loading capacity) in anhydrous DCM or DMF. Add DIPEA (5–10 equivalents). Transfer the solution to the swollen resin and agitate for 60–120 minutes at room temperature under inert atmosphere if possible. The reaction efficiency can be monitored by a qualitative Kaiser (ninhydrin) test on a small aliquot of resin after Fmoc removal.

Step 3: Capping Unreacted Sites

After loading, drain the amino acid solution. Add a capping solution of MeOH/DIPEA/DCM (1:1:8, v/v/v; approximately 5 mL per gram of resin) and agitate for 15–20 minutes. This converts unreacted trityl chloride groups to trityl methyl ether, preventing deletion sequences. Wash the resin thoroughly with DCM (3×), DMF (3×), and DCM (3×).

Step 4: Fmoc Removal and Chain Elongation

Remove the Fmoc protecting group by treatment with 20% piperidine in DMF (1×5 min, then 1×20 min). Wash with DMF (5×). Proceed with standard Fmoc SPPS coupling cycles using appropriate coupling reagents and Fmoc-amino acids for each subsequent residue. Monitor coupling completion with Kaiser or chloranil tests.

Step 5: Final Wash and Cleavage

After completing the full sequence, wash the resin with DMF (3×), DCM (3×), and dry briefly under a nitrogen stream. For mild cleavage yielding protected peptide or free peptide acid: treat the resin with AcOH/TFE/DCM (1:1:8, v/v/v) or 1–2% TFA in DCM for 30–60 minutes at room temperature with gentle agitation. Filter, collect the filtrate, and wash the resin with additional DCM (2×). Combine filtrates, concentrate under reduced pressure or nitrogen stream, and precipitate the peptide in cold diethyl ether if full deprotection was performed, or proceed directly to further chemistry if protected fragments are desired.

Troubleshooting and Tips

Low loading efficiency: Ensure the amino acid, DIPEA, and DCM are strictly anhydrous. Moisture rapidly hydrolyzes the reactive trityl chloride groups before they can react with the amino acid carboxylate. Pre-dry the resin and all solvents over molecular sieves if necessary.

Racemization concerns: 2-CTC Resin is specifically designed to minimize racemization. Use a hindered, non-nucleophilic base such as DIPEA rather than triethylamine to further reduce epimerization risk during loading.

Incomplete cleavage: Extend the cleavage time or increase the proportion of TFA (up to 5%) cautiously. Note that higher TFA concentrations may begin to remove acid-sensitive protecting groups such as Boc or tBu groups prematurely.

Peptide precipitation: If the target peptide precipitates during cleavage, add a small volume of DMF or DMSO to improve solubility. For hydrophobic sequences, consider using TFE/DCM mixtures.

Resin storage: Store 2-CTC Resin tightly sealed under dry, inert conditions away from moisture and protic solvents. Once the resin container is opened, use desiccants and re-seal promptly.

Frequently asked questions

Why is 2-Chlorotrityl Chloride Resin preferred over Wang resin for protected peptide fragment synthesis?

2-CTC Resin is significantly more acid-labile than Wang resin, allowing cleavage of fully protected peptide fragments using very mild acidic conditions (e.g., 1–2% TFA in DCM or AcOH/TFE/DCM) that leave all side-chain protecting groups intact. Wang resin requires stronger acid conditions that typically remove tBu-based side-chain protecting groups during cleavage. Additionally, 2-CTC Resin exhibits lower racemization during the loading step due to the steric environment of the chlorotrityl linker.

How do I determine the actual loading capacity of 2-Chlorotrityl Chloride Resin?

After loading the first amino acid and capping unreacted sites, remove the Fmoc group from a pre-weighed aliquot of dry resin using 20% piperidine in DMF. Measure the UV absorbance of the dibenzofulvene-piperidine adduct at 301 nm (ε ≈ 7,800 M⁻¹cm⁻¹). Calculate loading in mmol/g using the absorbance, volume, and dry resin weight. Always verify against the supplier's certificate of analysis for the lot in use.

Can 2-Chlorotrityl Chloride Resin be used to attach substrates other than Fmoc-amino acids?

Yes. The highly reactive trityl chloride group can form ester linkages with a wide variety of carboxylic acids and ester linkages or ether linkages with primary alcohols and phenols. This versatility makes 2-CTC Resin useful for immobilizing carboxylic acid-containing building blocks, linkers, or small molecules for solid-phase organic synthesis beyond peptide chemistry.

What safety precautions should be observed when handling 2-Chlorotrityl Chloride Resin?

2-CTC Resin releases HCl upon contact with moisture, which can cause irritation to the skin, eyes, and respiratory tract. Handle the resin in a well-ventilated fume hood, wear appropriate PPE (gloves, lab coat, safety goggles), and keep the resin away from water and protic solvents during storage and use. Consult the Safety Data Sheet (SDS) for the specific product before handling.

References

1. Barlos, K. et al. Darstellung geschützter Peptid-Fragmente unter Einsatz substituierter Triphenylmethyl-Harze. Liebigs Annalen der Chemie, 1989.
2. Fields, G.B.; Noble, R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. International Journal of Peptide and Protein Research, 1990, 35, 161–214.
3. Chan, W.C.; White, P.D. (Eds.) Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press, 2000.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.